Preferred Label : Guilhot CML 2007 Oncology Response Criteria;
NCIt related terms : GUILHOT CML 2007;
Alternative definition : CDISC: Dasatinib induces significant hematologic and cytogenetic responses in patients
with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
(Guilhot F, Apperley J, Kim DW, Bullorsky EO, Baccarani M, Roboz GJ, Amadori S, de
Souza CA, Lipton JH, Hochhaus A, Heim D, Larson RA, Branford S, Muller MC, Agarwal
P, Gollerkeri A, Talpaz M. Dasatinib induces significant hematologic and cytogenetic
responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia
in accelerated phase. Blood. 2007 May 15;109(10):4143-50. Epub 2007 Jan 30.);
NCI Metathesaurus CUI : CL504609;
Origin ID : C126009;
UMLS CUI : C4289023;
Semantic type(s)
- concept_is_in_subset
